Cancer specialist input in MCO coverage in U.S. 2018

This statistic depicts the cancer specialist input into MCO (managed care organization) coverage policy development in the United States, as of 2018. Some 20 percent of MCOs stated they have direct oncology specialist input in survivorship planning care.

Cancer specialist input into MCO coverage policy development in the United States as of 2018

Specialist input	Percentage of respondents
Genetic testing and counseling in oncology	62%
Molecular/biomarker testing in oncology (Pathologists input)	58%
Molecular/biomarker testing in oncology (Oncologists input)	57%
Next-generation sequencing in oncology	44%
Advance care planning and palliative care	39%
Survivorship planning care	20%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

May 2019

More information

Region

United States

Survey time period

November and December 2018

Number of respondents

97 managed care organizations (MCOs)

Method of interview

Online survey

Supplementary notes

The survey in total includes data from following groups: managed care organizations (MCOs), specialty pharmacies (SPs), oncologists, oncology practice managers (OPMs), employers that sponsor health benefits.

Citation formats